1444535-16-3

Upstream product

• 1013-88-3 Benzophenone imine 
• 119329-48-5 racemic 3-amino-1-methylpyrrolidin-2-one 

Downstream Products

• 1444535-91-4 tert-butyl N-[(3S)-1-methyl-2-oxo-3-[3-[4-[3-(trifluoromethoxy)phenyl]-2-pyridyl]prop-2-ynyl]pyrrolidin-3-yl]carbamate 
• 1444535-97-0 (3S)-3-amino-1-methyl-3-[3-[4-[3-(trifluoromethoxy)phenyl]-2-pyridyl]prop-2-ynyl]pyrrolidin-2-one 
• 1444536-03-1 (5S)-7-methyl-2-[4-[3-(trifluoromethoxy)phenyl]-2-pyridyl]-1,7-diazaspiro[4.4]non-1-en-6-one 
• 1444536-39-3 (2R,5S)-7-methyl-2-[4-[3-(trifluoromethoxy)phenyl]-2-pyridyl]-1,7-diazaspiro[4.4]nonan-6-one 
• 1444536-27-9 (2S,5S)-7-methyl-6-oxo-2-[4-[3-(trifluoromethoxy)phenyl]-2-pyridyl]-1,7-diazaspiro[4.4]nonane 
• 1444535-27-6 3-(benzhydrylideneamino)-1-methyl-3-(prop-2-ynyl)pyrrolidin-2-one 

Relevant academic research and scientific papers

2 - (PYRIDIN- 2YL) - 1, 7 -DIAZA-SPIRO [4.4] NONANE- 6 -ONE COMPOUND AS VOLTAGE-GATED SODIUM CHANNELS MODULATOR

The invention relates to spiro derivative of formula (I), to the use of said derivative in treating diseases and conditions mediated by modulation of voltage-gated sodium channels, to compositions containing said derivative and processes for its preparation.

Novel Compounds

NOVEL COMPOUNDS The invention relates to spiro derivatives, to the use of said derivatives intreating diseases and conditions mediated by modulation of voltage-gated sodium channels, to compositions containing said derivatives and processes for their preparation.